Harrison D A, Hodge D O, Bourne W M
Department of Ophthalmology, Mayo Clinic, Rochester, Minn., USA.
Arch Ophthalmol. 1995 Jun;113(6):753-6. doi: 10.1001/archopht.1995.01100060079036.
To determine if melanomas have occurred in the recipients of corneas from donor eyes with primary choroidal melanomas and to determine the success of corneal grafting with tissue taken from eyes with primary choroidal melanomas.
Retrospective cohort comparison and follow-up patient questionnaire.
A tertiary medical center in Rochester, Minn.
In patients who received corneal transplants, we reviewed 47 consecutive corneas transplanted from donor eyes enucleated for choroidal melanomas and compared them with 47 corneal grafts from donor eyes without melanomas matched for recipient age (+/- 10 years), date of operation (+/- 12 months), corneal storage time (+/- 24 hours), and operation type.
No melanomas occurred in either group over a mean follow-up of 5.4 years (range, 0.4 to 15 years). There was no significant difference between the two groups in corneal thickness and endothelial cell loss at 2 months and 1 year after transplantation and in the probability of a rejection episode.
There is no evidence of tumor transmission by transplantation of corneas from donor eyes with primary choroidal melanomas. Corneas transplanted from donor eyes with primary choroidal melanomas have similar outcomes to corneas transplanted from donor eyes without melanomas.
确定接受原发性脉络膜黑色素瘤供体眼角膜移植的受者是否发生黑色素瘤,并确定使用原发性脉络膜黑色素瘤眼组织进行角膜移植的成功率。
回顾性队列比较及随访患者问卷调查。
明尼苏达州罗切斯特的一家三级医疗中心。
在接受角膜移植的患者中,我们回顾了连续47例从因脉络膜黑色素瘤而摘除的供体眼中移植的角膜,并将其与47例来自无黑色素瘤供体眼的角膜移植片进行比较,这些供体眼在受者年龄(±10岁)、手术日期(±12个月)、角膜保存时间(±24小时)和手术类型方面进行了匹配。
在平均5.4年(范围0.4至15年)的随访期内,两组均未发生黑色素瘤。两组在移植后2个月和1年时的角膜厚度、内皮细胞损失以及排斥反应发生率方面无显著差异。
没有证据表明原发性脉络膜黑色素瘤供体眼的角膜移植会导致肿瘤传播。原发性脉络膜黑色素瘤供体眼移植的角膜与无黑色素瘤供体眼移植的角膜具有相似的结果。